TELA Bio, Inc. (TELA) stock
TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.76+0.00 (+0.07%)
Close on Nov 17, 2026Market cap $34.21MP/E –Yield –
TELA Bio gross margin
Gross margin is gross profit as a percentage of revenue.
TELA Bio's gross margin for the twelve months ending Jun 30, 2026 was 67.8%. For fiscal 2025 it was 67.7%, against 67.1% the year before. The highest annual figure on record is 68.6% in fiscal 2023.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 67.7% | +0.6 |
| FY2024 | Dec 31, 2024 | 67.1% | −1.5 |
| FY2023 | Dec 31, 2023 | 68.6% | +3.3 |
| FY2022 | Dec 31, 2022 | 65.3% | +1.4 |
| FY2021 | Dec 31, 2021 | 63.9% | +2.2 |
| FY2020 | Dec 31, 2020 | 61.7% | +1.7 |
| FY2019 | Dec 31, 2019 | 60.0% | +24.5 |
| FY2018 | Dec 31, 2018 | 35.6% | −24.1 |
| FY2017 | Dec 31, 2017 | 59.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 72.3% | +2.4 |
| Q1 FY2026 | Mar 31, 2026 | 65.7% | −1.9 |
| Q4 FY2025 | Dec 31, 2025 | 65.9% | +2.3 |
| Q3 FY2025 | Sep 30, 2025 | 67.5% | −0.3 |
| Q2 FY2025 | Jun 30, 2025 | 69.8% | +1.0 |
| Q1 FY2025 | Mar 31, 2025 | 67.6% | −0.7 |
| Q4 FY2024 | Dec 31, 2024 | 63.6% | −4.8 |
| Q3 FY2024 | Sep 30, 2024 | 67.8% | −1.2 |
| Q2 FY2024 | Jun 30, 2024 | 68.8% | −1.6 |
| Q1 FY2024 | Mar 31, 2024 | 68.3% | +2.0 |
| Q4 FY2023 | Dec 31, 2023 | 68.4% | −2.0 |
| Q3 FY2023 | Sep 30, 2023 | 69.0% | +3.4 |
| Q2 FY2023 | Jun 30, 2023 | 70.4% | +7.4 |
| Q1 FY2023 | Mar 31, 2023 | 66.3% | +5.6 |
| Q4 FY2022 | Dec 31, 2022 | 70.3% | +2.8 |
| Q3 FY2022 | Sep 30, 2022 | 65.6% | +5.5 |
| Q2 FY2022 | Jun 30, 2022 | 62.9% | −4.4 |
| Q1 FY2022 | Mar 31, 2022 | 60.7% | +1.8 |
| Q4 FY2021 | Dec 31, 2021 | 67.6% | +3.0 |
| Q3 FY2021 | Sep 30, 2021 | 60.1% | −1.7 |
| Q2 FY2021 | Jun 30, 2021 | 67.3% | +7.9 |
| Q1 FY2021 | Mar 31, 2021 | 59.0% | −0.1 |
| Q4 FY2020 | Dec 31, 2020 | 64.6% | +6.9 |
| Q3 FY2020 | Sep 30, 2020 | 61.9% | +7.5 |
| Q2 FY2020 | Jun 30, 2020 | 59.5% | +17.1 |
| Q1 FY2020 | Mar 31, 2020 | 59.0% | −2.8 |
| Q2 FY2019 | Jun 30, 2019 | 57.7% | – |
| Q1 FY2019 | Mar 31, 2019 | 54.4% | – |
| Q4 FY2018 | Dec 31, 2018 | 42.4% | – |
| Q3 FY2018 | Sep 30, 2018 | 61.8% | – |
See a number that looks wrong?